{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T18:06:23Z","timestamp":1772820383837,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"S16","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2105-15-s16-s13","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T12:03:05Z","timestamp":1418040185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Computational identification of novel natural inhibitors of glucagon receptor for checking type II diabetes mellitus"],"prefix":"10.1186","volume":"15","author":[{"given":"Sonam","family":"Grover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaspreet Kaur","family":"Dhanjal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukriti","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Durai","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,8]]},"reference":[{"issue":"9785","key":"6746_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","volume":"378","author":"G Danaei","year":"2011","unstructured":"Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA: National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011, 378 (9785): 31-40. 10.1016\/S0140-6736(11)60679-X.","journal-title":"Lancet"},{"issue":"4","key":"6746_CR2","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nrd2518","volume":"7","author":"MC Lagerstrom","year":"2008","unstructured":"Lagerstrom MC, Schioth HB: Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov. 2008, 7 (4): 339-357. 10.1038\/nrd2518.","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"6746_CR3","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1359-6446(05)03370-2","volume":"10","author":"SR Hoare","year":"2005","unstructured":"Hoare SR: Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors. Drug Discov Today. 2005, 10 (6): 417-427. 10.1016\/S1359-6446(05)03370-2.","journal-title":"Drug Discov Today"},{"issue":"3","key":"6746_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/aps.2011.170","volume":"33","author":"K Pal","year":"2012","unstructured":"Pal K, Melcher K, Xu HE: Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors. Acta Pharmacol Sin. 2012, 33 (3): 300-311. 10.1038\/aps.2011.170.","journal-title":"Acta Pharmacol Sin"},{"issue":"3","key":"6746_CR5","doi-asserted-by":"publisher","first-page":"E415","DOI":"10.1152\/ajpendo.90887.2008","volume":"296","author":"S Ali","year":"2009","unstructured":"Ali S, Drucker DJ: Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes. Am J Physiol Endocrinol Metab. 2009, 296 (3): E415-421.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"6746_CR6","doi-asserted-by":"publisher","first-page":"E671","DOI":"10.1152\/ajpendo.00492.2002","volume":"284","author":"G Jiang","year":"2003","unstructured":"Jiang G, Zhang BB: Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab. 2003, 284 (4): E671-678. 10.1152\/ajpendo.00492.2002.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"2","key":"6746_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2337\/db10-0426","volume":"60","author":"Y Lee","year":"2011","unstructured":"Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH: Glucagon Receptor Knockout Prevents Insulin-Deficient Type 1 Diabetes in Mice. Diabetes. 2011, 60 (2): 391-397. 10.2337\/db10-0426.","journal-title":"Diabetes"},{"issue":"7","key":"6746_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/BF00280887","volume":"28","author":"K Tan","year":"1985","unstructured":"Tan K, Tsiolakis D, Marks V: Effect of Glucagon Antibodies on Plasma-Glucose, Insulin and Somatostatin in the Fasting and Fed Rat. Diabetologia. 1985, 28 (7): 435-440. 10.1007\/BF00280887.","journal-title":"Diabetologia"},{"issue":"3","key":"6746_CR9","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1517\/14728222.9.3.593","volume":"9","author":"KW Sloop","year":"2005","unstructured":"Sloop KW, Michael MD, Moyers JS: Glucagon as a target for the treatment of Type 2 diabetes. Expert Opin Ther Tar. 2005, 9 (3): 593-600. 10.1517\/14728222.9.3.593.","journal-title":"Expert Opin Ther Tar"},{"issue":"12","key":"6746_CR10","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.2337\/diabetes.53.12.3267","volume":"53","author":"SA Qureshi","year":"2004","unstructured":"Qureshi SA, Candelore MR, Xie D, Yang XD, Tota LM, Ding VDH, Li ZH, Bansal A, Miller C, Cohen SM: A novel glucagon receptor antagonist inhibits glucagon-mediated biological effects. Diabetes. 2004, 53 (12): 3267-3273. 10.2337\/diabetes.53.12.3267.","journal-title":"Diabetes"},{"issue":"1","key":"6746_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1021\/jm058026u","volume":"50","author":"J Lau","year":"2007","unstructured":"Lau J, Behrens C, Sidelmann UG, Knudsen LB, Lundt B, Sams C, Ynddal L, Brand CL, Pridal L, Ling A: New beta-alanine derivatives are orally available glucagon receptor antagonists. J Med Chem. 2007, 50 (1): 113-128. 10.1021\/jm058026u.","journal-title":"J Med Chem"},{"issue":"3","key":"6746_CR12","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.bmcl.2006.11.014","volume":"17","author":"R Liang","year":"2007","unstructured":"Liang R, Abrardo L, Brady EJ, Candelore MR, Ding V, Saperstein R, Tota LM, Wright M, Mock S, Tamvakopolous C: Design and synthesis of conformationally constrained tri-substituted ureas as potent antagonists of the human glucagon receptor. Bioorg Med Chem Lett. 2007, 17 (3): 587-592. 10.1016\/j.bmcl.2006.11.014.","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"6746_CR13","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.1016\/j.bmcl.2008.05.072","volume":"18","author":"RM Kim","year":"2008","unstructured":"Kim RM, Chang J, Lins AR, Brady E, Candelore MR, Dallas-Yang Q, Ding V, Dragovic J, Iliff S, Jiang GQ: Discovery of potent, orally active benzimidazole glucagon receptor antagonists. Bioorg Med Chem Lett. 2008, 18 (13): 3701-3705. 10.1016\/j.bmcl.2008.05.072.","journal-title":"Bioorg Med Chem Lett"},{"issue":"9","key":"6746_CR14","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1021\/jm8016249","volume":"52","author":"P Madsen","year":"2009","unstructured":"Madsen P, Kodra JT, Behrens C, Nishimura E, Jeppesen CB, Pridal L, Andersen B, Knudsen LB, Valcarce-Aspegren C, Guldbrandt M: Human Glucagon Receptor Antagonists with Thiazole Cores. A Novel Series with Superior Pharmacokinetic Properties. J Med Chem. 2009, 52 (9): 2989-3000. 10.1021\/jm8016249.","journal-title":"J Med Chem"},{"key":"6746_CR15","doi-asserted-by":"crossref","unstructured":"Mu J, Qureshi SA, Brady EJ, Muise ES, Candelore MR, Jiang GQ, Li ZH, Wu MS, Yang XD, Dallas-Yang Q: Anti-Diabetic Efficacy and Impact on Amino Acid Metabolism of GRA1, a Novel Small-Molecule Glucagon Receptor Antagonist. Plos One. 2012, 7 (11):","DOI":"10.1371\/journal.pone.0049572"},{"issue":"14","key":"6746_CR16","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.2174\/138161206776873671","volume":"12","author":"JL Estall","year":"2006","unstructured":"Estall JL, Drucker DJ: Glucagon and glucagon-like peptide receptors as drug targets. Curr Pharm Design. 2006, 12 (14): 1731-1750. 10.2174\/138161206776873671.","journal-title":"Curr Pharm Design"},{"issue":"4","key":"6746_CR17","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1124\/mol.109.060111","volume":"77","author":"T Yaqub","year":"2010","unstructured":"Yaqub T, Tikhonova IG, Lattig J, Magnan R, Laval M, Escrieut C, Boulegue C, Hewage C, Fourmy D: Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand. Mol Pharmacol. 2010, 77 (4): 547-558. 10.1124\/mol.109.060111.","journal-title":"Mol Pharmacol"},{"issue":"Pt 4","key":"6746_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1042\/BST0350709","volume":"35","author":"LJ Miller","year":"2007","unstructured":"Miller LJ, Dong M, Harikumar KG, Gao F: Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor. Biochem Soc Trans. 2007, 35 (Pt 4): 709-712.","journal-title":"Biochem Soc Trans"},{"issue":"12","key":"6746_CR19","doi-asserted-by":"publisher","first-page":"5092","DOI":"10.1096\/fj.12-212399","volume":"26","author":"MQ Dong","year":"2012","unstructured":"Dong MQ, Xu XQ, Ball AM, Makhoul JA, Lam PCH, Pinon DI, Orry A, Sexton PM, Abagyan R, Miller LJ: Mapping spatial approximations between the amino terminus of secretin and each of the extracellular loops of its receptor using cysteine trapping. Faseb J. 2012, 26 (12): 5092-5105. 10.1096\/fj.12-212399.","journal-title":"Faseb J"},{"issue":"18","key":"6746_CR20","doi-asserted-by":"publisher","first-page":"15895","DOI":"10.1074\/jbc.M110.217901","volume":"286","author":"LJ Miller","year":"2011","unstructured":"Miller LJ, Chen Q, Lam PC, Pinon DI, Sexton PM, Abagyan R, Dong M: Refinement of glucagon-like peptide 1 docking to its intact receptor using mid-region photolabile probes and molecular modeling. J Biol Chem. 2011, 286 (18): 15895-15907. 10.1074\/jbc.M110.217901.","journal-title":"J Biol Chem"},{"issue":"27","key":"6746_CR21","doi-asserted-by":"publisher","first-page":"23888","DOI":"10.1074\/jbc.M111.245969","volume":"286","author":"M Dong","year":"2011","unstructured":"Dong M, Lam PCH, Pinon DI, Hosohata K, Orry A, Sexton PM, Abagyan R, Miller LJ: Molecular Basis of Secretin Docking to Its Intact Receptor Using Multiple Photolabile Probes Distributed throughout the Pharmacophore. J Biol Chem. 2011, 286 (27): 23888-23899. 10.1074\/jbc.M111.245969.","journal-title":"J Biol Chem"},{"issue":"12","key":"6746_CR22","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1210\/me.2003-0275","volume":"17","author":"RC Gensure","year":"2003","unstructured":"Gensure RC, Shimizu N, Tsang J, Gardella TJ: Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor. Mol Endocrinol. 2003, 17 (12): 2647-2658. 10.1210\/me.2003-0275.","journal-title":"Mol Endocrinol"},{"issue":"12","key":"6746_CR23","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1002\/cmdc.201100317","volume":"6","author":"C de Graaf","year":"2011","unstructured":"de Graaf C, Rein C, Piwnica D, Giordanetto F, Rognan D: Structure-based discovery of allosteric modulators of two related class B G-protein-coupled receptors. ChemMedChem. 2011, 6 (12): 2159-2169. 10.1002\/cmdc.201100317.","journal-title":"ChemMedChem"},{"issue":"7459","key":"6746_CR24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature12393","volume":"499","author":"FY Siu","year":"2013","unstructured":"Siu FY, He M, de Graaf C, Han GW, Yang DH, Zhang ZY, Zhou CH, Xu QP, Wacker D, Joseph JS: Structure of the human glucagon class B G-protein-coupled receptor. Nature. 2013, 499 (7459): 444-+. 10.1038\/nature12393.","journal-title":"Nature"},{"key":"6746_CR25","unstructured":"Schrodinger, Maestro, version 9, LLC. 2009, New York, NY, USA"},{"issue":"6","key":"6746_CR26","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1074\/jbc.M806715200","volume":"284","author":"S Sreeramulu","year":"2009","unstructured":"Sreeramulu S, Jonker HR, Langer T, Richter C, Lancaster CR, Schwalbe H: The human Cdc37.Hsp90 complex studied by heteronuclear NMR spectroscopy. J Biol Chem. 2009, 284 (6): 3885-3896. 10.1074\/jbc.M806715200.","journal-title":"J Biol Chem"},{"issue":"37","key":"6746_CR27","doi-asserted-by":"publisher","first-page":"12316","DOI":"10.1021\/bi050801k","volume":"44","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Raushel FM, Shoichet BK: Virtual screening against metalloenzymes for inhibitors and substrates. Biochemistry. 2005, 44 (37): 12316-12328. 10.1021\/bi050801k.","journal-title":"Biochemistry"},{"key":"6746_CR28","unstructured":"Schrodinger, Ligprep, version 2.3, LLC. 2009, New York, NY, USA"},{"issue":"7","key":"6746_CR29","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, Banks JL: Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004, 47 (7): 1750-1759. 10.1021\/jm030644s.","journal-title":"J Med Chem"},{"issue":"7","key":"6746_CR30","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry JK: Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem. 2004, 47 (7): 1739-1749. 10.1021\/jm0306430.","journal-title":"J Med Chem"},{"issue":"7","key":"6746_CR31","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/aps.2009.84","volume":"30","author":"J Qian","year":"2009","unstructured":"Qian J, Zhu CH, Tang S, Shen AJ, Ai J, Li J, Geng MY, Ding J: alpha2,6-hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells. Acta Pharmacol Sin. 2009, 30 (7): 1039-1045. 10.1038\/aps.2009.84.","journal-title":"Acta Pharmacol Sin"},{"issue":"6","key":"6746_CR32","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1021\/ci1000407","volume":"50","author":"M Sandor","year":"2010","unstructured":"Sandor M, Kiss R, Keseru GM: Virtual fragment docking by Glide: a validation study on 190 protein-fragment complexes. J Chem Inf Model. 2010, 50 (6): 1165-1172. 10.1021\/ci1000407.","journal-title":"J Chem Inf Model"},{"issue":"4","key":"6746_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1747-0285.2010.00951.x","volume":"75","author":"Z Guo","year":"2010","unstructured":"Guo Z, Mohanty U, Noehre J, Sawyer TK, Sherman W, Krilov G: Probing the alpha-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis. Chemical biology & drug design. 2010, 75 (4): 348-359. 10.1111\/j.1747-0285.2010.00951.x.","journal-title":"Chemical biology & drug design"},{"key":"6746_CR34","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML: Comparison of simple potential functions for simulating liquid water. The Journal of chemical physics. 1983, 79: 926-10.1063\/1.445869.","journal-title":"The Journal of chemical physics"},{"issue":"2","key":"6746_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/protein\/8.2.127","volume":"8","author":"AC Wallace","year":"1995","unstructured":"Wallace AC, Laskowski RA, Thornton JM: LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein engineering. 1995, 8 (2): 127-134. 10.1093\/protein\/8.2.127.","journal-title":"Protein engineering"},{"issue":"13","key":"6746_CR36","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.1021\/jm300579z","volume":"55","author":"Y Xiong","year":"2012","unstructured":"Xiong Y, Guo J, Candelore MR, Liang R, Miller C, Dallas-Yang Q, Jiang G, McCann PE, Qureshi SA, Tong X: Discovery of a novel glucagon receptor antagonist N-[(4-{(1S)-1-[3-(3, 5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbo nyl]-beta-alanine (MK-0893) for the treatment of type II diabetes. J Med Chem. 2012, 55 (13): 6137-6148. 10.1021\/jm300579z.","journal-title":"J Med Chem"},{"key":"6746_CR37","first-page":"A84","volume":"60","author":"GP Kelly RP","year":"2011","unstructured":"Kelly RP GP, Abu-Raddad EJ, Fu H, Lim CN, Prince MJ, Pinaire JA, Loh MT, Deeg MA: Short-term treatment with glucagon receptor antagonist LY2409021 effectively reduces fasting blood glucose and HbA1c in patients with type 2 diabetes mellitus. Diabetes. 2011, 60: A84-","journal-title":"Diabetes"},{"key":"6746_CR38","unstructured":"QuickProp. version 3.2 edn: Schr\u00f6dinger. 2009, LLC, New York, NY"},{"issue":"30","key":"6746_CR39","doi-asserted-by":"publisher","first-page":"28005","DOI":"10.1074\/jbc.M301085200","volume":"278","author":"S Runge","year":"2003","unstructured":"Runge S, Gram C, Brauner-Osborne H, Madsen K, Knudsen LB, Wulff BS: Three distinct epitopes on the extracellular face of the glucagon receptor determine specificity for the glucagon amino terminus. J Biol Chem. 2003, 278 (30): 28005-28010. 10.1074\/jbc.M301085200.","journal-title":"J Biol Chem"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-15-S16-S13.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:07:57Z","timestamp":1630609677000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-15-S16-S13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":39,"journal-issue":{"issue":"S16","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["6746"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-15-s16-s13","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"8 December 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S13"}}